[#DIV28SUPER] T32 positions available at the University of Kentucky

The University of Kentucky NIDA-funded T32 (T32DA0035200; Research Training on Drug Abuse Behavior) will be accepting applications for six (6) training positions (three [3] pre-doctoral and three [3] post-doctoral slots). Please recall only US citizens or permanent residents are eligible. NIH reviews the training grant with respect to a demonstration of the ability to recruit excellent trainees who are from demographic groups underrepresented in science. If you know of someone who is interested and eligible, please encourage them to apply. Please also forward this message to anyone who might be interested. 

We are asking the proposed faculty supervisor(s) of the applicants to gather all the documents requested in the attached document. Please assemble these materials into a single PDF and email to Dr. Craig Rush (crush2@uky.edu) by noon Eastern on April 15, 2022. Please use the following file-naming conventions: LastName_FirstName_Pre_2021 for pre-doctoral applications and LastName_FirstName_Post_2021 for post-doctoral applications.  For a list of T32 training faculty supervisors, please also contact Dr. Rush. A selection committee will then rate the applicants and the most qualified applicants will be offered the positions. Priority will be given to those candidates who propose to work on NIDA-funded or NIDA-related projects. We will complete the selection process during April. 

 

Thank you in advance for encouraging qualified candidates to apply. Please feel free to contact Dr. Rush if you have any questions. 

               
---------------------------------------------------------------------------------
William W. Stoops, Ph.D.
email: william.stoops@uky.edu
telephone: (859) 257-5383

Professor
Departments of Behavioral Science, Psychiatry and Psychology
Center on Drug and Alcohol Research
University of Kentucky

Director
Regulatory Knowledge and Support Core-Center for Clinical and Translational Science

Clinical Research Support Office

Associate Director for Clinical Research

Substance Use Priority Research Area

STATEMENT OF CONFIDENTIALITY
The contents of this e-mail message and any attachments are confidential and are intended solely for the addressee. The information may also be legally privileged. This transmission is sent in trust, for the sole purpose of delivery to the intended recipient. If you have received this transmission in error, any use, reproduction or dissemination of this transmission is strictly prohibited. If you are not the intended recipient, please immediately notify the sender by reply e-mail or at (859) 257-5383 and delete this message and its attachments, if any.

[#DIV28SUPER] We are Hiring: Postdoctoral Trainee interested in opioid human clinical trials

Hello colleagues,

Please share this postdoctoral training opportunity for persons interested in rigorous opioid research trials. Contact me directly with interest or questions

Kelly Dunn, kdunn9@jhmi.edu; 410-550-2254.

---

 

---
Kelly Dunn, Ph.D., M.B.A.

Associate Professor
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
P:410-550-2254; F:410-550-0030

[#DIV28SUPER] Position Announcement: JHU School of Public Health, Dept. of Mental Health, Chair

Bloomberg Centennial Professor and Chair, Department of Mental Health

The Johns Hopkins Bloomberg School of Public Health invites applications for the Bloomberg Centennial Professor and Chair of the Department of Mental Health. The successful applicant will have an outstanding record of academic and research accomplishments, demonstrated leadership and administrative abilities, a public health perspective on mental health, and a compelling vision for the Department. The Department of Mental Health seeks to advance understanding of mental health and substance use disorders, with a strong focus on etiology and the development and implementation of programs and policies to advance public mental health and health equity in a range of community, school, and workplace settings. The department brings together researchers and practitioners from multiple disciplines to understand, prevent, and treat mental health and substance use conditions. Founded over 60 years ago, the Department is still the only Department of Mental Health in a school of public health. It has 57 full time faculty, 69 doctoral and master's students and multiple post-doctoral fellows who are working domestically and internationally across a diverse set of disciplines including epidemiology, biostatistics, psychology, sociology, psychiatry, and health policy applied to critical public mental health challenges across the life course from developmental disabilities through adolescent and adult mental health, severe mental illness, and cognitive aging. The department is one of 10 academic departments at the Bloomberg School. The School is consistently ranked among the top schools of public health in the country with more than 870 full-time faculty and 2,700 graduate-level students. The main campus of the School is located on the medical campus in East Baltimore. Both the East Baltimore campus and the broader University support a collaborative and highly interactive environment with a superb research infrastructure. The Johns Hopkins University is committed to equal opportunity for its faculty, staff, and students. To that end, the university does not discriminate on the basis of sex, gender, marital status, pregnancy, race, color, ethnicity, national origin, age, disability, religion, sexual orientation, gender identity or expression, veteran status, military status, immigration status, or other legally protected characteristic. The university is committed to providing qualified individuals access to all academic and employment programs, benefits, and activities on the basis of demonstrated ability, performance, and merit without regard to personal factors that are irrelevant to the program involved.

Applications should include 1) curriculum vitae; 2) statement of academic interest and vision of leadership; and 3) statement of demonstrated commitment to the principles of inclusion, diversity, anti-racism, and equity (IDARE) in scholarship, teaching, policy, and practice, and ways to continue to promote and advance these principles in their leadership of the Department. Review of candidates will begin April 1, 2022. Please direct all questions about this search to Susan Williams, Administrative Specialist, at swilli94@jhu.edu.

Applications should be submitted to: http://apply.interfolio.com/102322

Apply - Interfolio Apply - Interfolio apply.interfolio.com



---
Kelly Dunn, Ph.D., M.B.A.

Associate Professor
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
P:410-550-2254; F:410-550-0030

---

 

********************************************************************************

[#DIV28SUPER] DEADLINE EXTENDED: MARCH 22 | Apply Now for Summer Training and $30,000 Research Grant - 2022 HIV/Drug Abuse Prevention Research Ethics Training Institute

SUMMER TRAINING & RESEARCH FUNDING FOR
EARLY CAREER INVESTIGATORS*

Apply to become a fellow of the NIDA-funded

Fordham University HIV & Drug Abuse Prevention
Research Ethics Training Institute

Celia B. Fisher, Ph.D.

Director & Principal Investigator (R25DA031608)

• Attend two summer training institutes: July 11-18, 2022 (In-Person, NYC) and July 2023 (TBD) with fully funded travel and lodging 
  
• Receive a $30,000 grant to conduct a mentored research study that will contribute to evidence-based HIV & drug abuse research ethics practice 
  
• Join an international network of scholars examining current challenges in HIV & drug abuse research ethics

* Our hope is to offer in-person training for Summer 2022. However, given the ongoing COVID-19 pandemic, we will offer hybrid (virtual) formats for those who are unable to attend in person. Any in-person training activities will be in compliance with New York State, New York City, and Fordham University policies on COVID-19 safety.

Institute alumni have published findings from their Institute-funded research in high impact journals, incorporated findings as pilot data for successful NIH grant applications, and have become recognized as experts in the responsible conduct of HIV and drug abuse research. To see our trainees' accomplishments, visit our publications page or the "HIV/AIDS & Drug Abuse Research Ethics" online collection at www.researchethics.net.

HOW AND WHEN TO APPLY

Visit www.fordham.edu/RETIapply for the application requirements and form, or contact Rimah Jaber at ethicsinst@fordham.edu for more information. Applications are due March 22, 2022. Applicants will be notified of award decisions by April 30, 2022.

--

Celia B. Fisher, PhD.

Marie Ward Doty University Chair in Ethics

Professor of Psychology, 

Director Center for Ethics Education

Director HIV and Drug Abuse Prevention Research Ethics Training Institute

Director, Human Development and Social Justice Lab

Fordham University, Dealy hall

441 East Fordham Road

Bronx, NY 10458

e. Fisher@fordham.edu  t. (718)817-3793  f. (718)817-0731

Administrative Assistant Lori Merone, lmerone@fordham.edu (718) 817-0926

HIV/Drug Abuse Program Administrator Rimah Jaber, ethicinst@fordham.edu (718) 817-0927

Follow the Ethics Center on Twitter and Facebook: @FordhamEthics and on our blog ethicsandsociety.org

Preferred pronouns: she, her, hers

   

_____________________________ div28SUPER@lists.apa.org
Div28m members may post here list archive
twitter: @apadiv28 #div28

[#DIV28SUPER] Quick Favor (Rich) ❤️

Hi, 

How are you doing? I need a favor from you. Do you shop on Amazon? Wondering if you can help me place an order.

Thanks.

Rich Mucowski

[#DIV28SUPER] Fw: Register Today! Methadone Treatment for Opioid Use Disorder: Examining Federal Regulations and Laws - A Workshop

Hello colleagues,

Please see below a webinar focused on methadone prescribing practices, with a hopeful emphasis on expanding access to methadone.

Warm regards,

Kelly

---
Kelly Dunn, Ph.D., M.B.A.

Associate Professor
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
P:410-550-2254; F:410-550-0030

---

View this email in your browser   Register Today!    Methadone Treatment for Opioid Use Disorder: Examining Federal Regulations and Laws: A Workshop March 3, 2022 | 9:30am-5:00pm ET March 4, 2022 | 9:30am-4:30pm ET   Opioid use disorder (OUD)—a chronic brain disease caused by prolonged use of prescription opioids, heroin, or other illicit opioids—imposes heavy costs on individuals, their families, and society. Methadone is one of three safe and highly effective medications that are approved by the U.S. Food and Drug Administration to treat OUD; however, stringent laws and regulatory policies pose substantial barriers to provision of and access to quality treatment.  On March 3-4, 2022, the National Academies of Sciences, Engineering, and Medicine'sBoard on Health Sciences Policy and Board on Health Care Services, and National Academy of Medicine's Action Collaborative on Countering the U.S. Opioid Epidemic will host a public workshop bringing together experts and key stakeholders to examine the current federal regulatory and legal landscape regarding provision of and access to methadone for the treatment of opioid use disorder.  Invited presentations and discussions will be designed to: Examine current federal regulations governing methadone treatment services, including the current COVID-19 emergency regulatory relief;  Discuss the impact of these regulations relative to other factors affecting treatment services;  Explore potential options for modifying federal regulations and laws to expand access to quality treatment with methadone; and Explore state laws that may conflict with federal regulations.  This workshop is sponsored by the Office of National Drug Control Policy, Executive Office of the President. For more information, including the planning committee slate and biographies, please visitour website.   Register Now

--

Kelly Dunn, Ph.D., MBA

Associate Professor

Behavioral Pharmacology Research Unit

Department of Psychiatry and Behavioral Science
Johns Hopkins University School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
BPRU Phone: (410) 550-2254
Fax: (410) 550-0030
 
WARNING:  E-mail sent over the Internet is not secure.  Information sent by e-mail may not remain confidential.
DISCLAIMER:  This e-mail is intended only for the individual to whom it is addressed.  It may be used only in accordance with applicable laws.  If you received this e-mail by mistake, notify the sender and destroy the e-mail

[#DIV28SUPER] NIDA Neuroscience Update, February 15, 2022

Table of Contents

I.                     Investigating Transposable Elements and Mobile DNA as Targets of Integration for Establishing HIV Reservoirs in the Brain (R61/R33 - Clinical Trial Optional)

II.                   Notice of Special Interest (NOSI): Administrative Supplements to Recognize Excellence in Diversity, Equity, Inclusion, and Accessibility (DEIA) Mentorship

III.                  The Virtual Short Course on the Genetics of Addiction and In-Person Research Experiences for Faculty and Student Teams Underrepresented in Science

IV.                 Brain Behavior Quantification and Synchronization (BBQS) workshop

----

 

I.  Investigating Transposable Elements and Mobile DNA as Targets of Integration for Establishing HIV Reservoirs in the Brain (R61/R33 - Clinical Trial Optional)

The purpose of this funding opportunity announcement is to support research examining the potential contributions of mobile DNA elements and addictive substances in HIV integration, reservoir formation, and maintenance in the brain. NIDA is specifically interested in studies exploring the contributions of molecular, genetic, and epigenetic factors in HIV integration, reservoir formation, and maintenance in microglia and/or the brain in the context of addiction.

https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-23-003.html

----

 

II.  Notice of Special Interest (NOSI): Administrative Supplements to Recognize Excellence in Diversity, Equity, Inclusion, and Accessibility (DEIA) Mentorship

The supplement awards will provide up to $250,000.00 (direct costs), not to exceed the cost of the parent award, to grants supporting faculty members who have mentoring and/or mentorship as part of their existing awards and have demonstrated a commitment to outstanding mentorship and training, especially to individuals from groups identified as underrepresented in the biomedical sciences (e.g., see the Notice of NIH's of Interest in Diversity). As administrative supplements, the work proposed needs to be within the scope of the research or training that is already supported. The award must have a component related to mentoring. Examples include but are not limited to: a Research Education Program that describes mentored research experiences, a Career Development section, a Plan to Enhance Diverse Perspectives, or a discrete objective related to mentoring.

https://grants.nih.gov/grants/guide/notice-files/NOT-OD-22-057.html

---

 

III.             The Virtual Short Course on the Genetics of Addiction and In-Person Research Experiences for Faculty and Student Teams Underrepresented in Science

https://www.jax.org/education-and-learning/education-calendar/2022/february/addiction-genetics#

This unique training experience combines our Annual Short Course in a virtual format with the opportunity for mentored research experiences: the goal is to support and expand a diverse community of academics in their pursuit and advancement of addiction-related education, research, and careers. The research experiences are designed for teams of faculty, postdoctoral fellows, and undergraduate and graduate students underrepresented in science for training and mentored research projects utilizing advanced methods and resources for addiction genetics.

Each day of the course will be held from 12pm-2pm (Eastern Time) M/W/F and focus on a general topic area. Sessions will be recorded and made available to registered attendees to view on-demand for two months following the course.

 

Course funding: 1R25DA051342 (NIH/NIDA; E. Chesler, PI); 5R13DA052199 (NIH/NIDA; E. Chesler, PI)

 

ENROLL IN THE ONLINE COURSE:

https://web.cvent.com/event/98db01c0-f610-41c7-9251-dfd791c34fb8/regProcessStep1

 

----

 

IV. Brain Behavior Quantification and Synchronization (BBQS) workshop

https://event.roseliassociates.com/bbqs-workshop/

The BRAIN Initiative invites you to attend the Brain Behavior Quantification and Synchronization (BBQS) workshop, hosted by the NIH Brain Initiative. The workshop will be held virtually on March 1-2, 2022 from 1:00 – 5:30 pm ET. The workshop will bring together innovators in bioengineering, computational science and informatics, cognitive neuroscience (both human and animal studies), evolutionary biology and ethology, social sciences, and ethics with the objective of identifying advances in research necessary for a more comprehensive understanding of behavior.

 

For more information and to REGISTER, click here.

 

 

The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L